Iterum Therapeutics plc (ITRMF) Assets Average (2018 - 2025)

Iterum Therapeutics has reported Assets Average for 8 years, with the latest figure at $33.3 million in Q3 2025.

• On a quarterly basis, Assets Average rose 121.0% year-over-year to $33.3 million in Q3 2025; TTM through Sep 2025 was $33.3 million, a 121.0% increase from a year earlier, with the FY2024 full-year figure at $35.4 million, down 23.89% from the prior year.
• Assets Average was $33.3 million for Q3 2025 at Iterum Therapeutics, down from $33.5 million in the prior quarter.
• The five-year high for Assets Average was $110.6 million in Q2 2021, with the low at $15.0 million in Q3 2024.
• Average Assets Average over 5 years is $56.8 million, with a median of $54.6 million recorded in 2023.
• The sharpest annual moves came in 2021 and 2024: Assets Average jumped 252.79% in 2021, then sank 69.03% in 2024.
• Over 5 years, Assets Average stood at $95.0 million in 2021, then slipped by 27.14% to $69.2 million in 2022, then slumped by 52.32% to $33.0 million in 2023, then fell by 8.29% to $30.3 million in 2024, then increased by 9.91% to $33.3 million in 2025.
• The last three Assets Average figures came in at $33.3 million (Q3 2025), $33.5 million (Q2 2025), and $38.8 million (Q1 2025), per Business Quant data.